Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-08
2011-03-08
Fetterolf, Brandon J (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S131000
Reexamination Certificate
active
07902235
ABSTRACT:
The present invention relates to methods, compounds, and compositions for treating or preventing diseases associated with nonsense mutations in an mRNA by administering the compounds or compositions of the present invention. More particularly, the present invention relates to methods, compounds, and compositions for suppressing premature translation termination associated with a nonsense mutation in an mRNA.
REFERENCES:
patent: WO 97/44333 (1997-11-01), None
patent: WO 2004/009558 (2004-01-01), None
patent: WO 2004/009610 (2004-01-01), None
STN Search Report Accession No. 1997:776160.
Han (Advances in Characterization of Pharmaceutical Hydrates. Trends in Bio/Pharmaceutical Industry, pp. 25-29. Mar. 2006).
Vippagunta et al (Adv Drug Deliv Rev 48:3-26, 2001).
International Search Report for PCT/US2005/037052, mailed Feb. 1, 2006.
Campbell Jeffrey A.
Kahn Atiyya
Takasugi James
Welch Ellen
Fetterolf Brandon J
Hoffmann & Baron , LLP
PTC Therapeutics, Inc.
Ricci Craig
LandOfFree
Compounds for nonsense suppression, and methods for their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds for nonsense suppression, and methods for their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for nonsense suppression, and methods for their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2672388